Skip to main content

Table 2 Perioperative characteristics

From: Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery

  

All patients

(n = 680)

Normal glucose

(n = 344)

Impaired fasting glucose

(n = 132)

Diabetes mellitus

(n = 204)

P value

Beta-blocker

 

157(23,1)

61(17,7)

33(25)

63(30,9)

0,002

Calcium inhibitor

 

99(14,6)

51(14,8)

16(12,1)

32(15,7)

0,651

ACE inhibitor

 

180(26,5)

75(21,8)

37(28)

68(33,3)

0,011

Furosemid

 

21(3,1)

10(2,9)

7(5,3)

4(2)

0,216

Thiazid

 

22(3,2)

10(2,9)

4(3)

8(3,9)

0,801

Sprinolactone

 

20(2,9)

8(2,3)

6(4,5)

6(2,9)

0,439

Aspirin

 

146(21,5)

47(13,7)

27(20,5)

72(35,3)

< 0,001

Statin

 

67(9,9)

17(4,9)

7(5,3)

43(21,1)

< 0,001

Digoxin

 

25(3,7)

10(2,9)

7(5,3)

8(3,9)

0,450

Anticoagulant

 

31(4,6)

11(3,2)

9(6,8)

11(5,4)

0,188

ARB

 

60(8,8)

25(7,3)

9(6,8)

26(12,7)

0,061

 

General

288(42,4)

143(41,6)

58(43,9)

87(42,6)

 
 

Urology

131(19,3)

70(20,3)

25(18,9)

36(17,6)

 
 

Plastics

32(4,7)

17(4,9)

7(5,3)

8(3,9)

 

Type of surgery

Gynecological

33(4,9)

18(5,2)

5(3,8)

10(4,9)

0,724

 

Orthopedic

160(23,5)

77(22,4)

35(26,5)

48(23,5)

 
 

Ophthalmologic

9(1,3)

4(1,2)

2(1,5)

3(1,5)

 
 

Neurological

19(2,8)

11(3,2)

1(0,8)

7(3,4)

 
 

Ear/nose/throat

8(1,2)

4(1,2)

2(1,5)

2(1)

 

Triglyceride (mg/dl)

143,4 ± 75,9

141,3 ± 85,5

137,9 ± 55,8

150,5 ± 69,4

0,182

High density lipoprotein (mg/dl)

45,6 ± 17,4

46,4 ± 18,4

45 ± 15,7

44,6 ± 16,7

0,323

Low density lipoprotein (mg/dl)

108,8 ± 32,7

107,4 ± 32,1

114,3 ± 36,3

107,6 ± 31

0,148

Creatinine (mg/dl)

1,2 ± 1,4

1,2 ± 1,6

1,2 ± 1,2

1,2 ± 1,1

0,163

Fasting glucose (mg/dl)

109,4 ± 38,7

86,8 ± 8,6

109,6 ± 7,3

147,6 ± 50,1

< 0,001

  1. Abbreviations: ACE = Angiotensin-converting enzyme inhibitor; ARB = angiotensin II-receptor blocker. Values are given as mean ± SD or number (percentage).